Leveraging Generis’ CARA Platform and Adlib Software for Compliance in Life Sciences

Regulatory compliance is the lifeblood of the life sciences industry. Every action, decision, and process within pharmaceutical companies, biotech firms, and medical device manufacturers is guided by stringent regulatory norms set by global and local regulatory bodies. Adhering to these regulations is not just about lawfulness—it’s about ensuring patient safety, product effectiveness, and maintaining the public’s trust in life sciences organizations.

Yet, managing compliance is a colossal challenge, especially on a global scale. The multiplicity of regulatory bodies across countries, each with their own unique and often shifting guidelines, create a maze that companies must navigate with precision and timeliness. A minor slip-up can result in serious implications, including heavy penalties, product recalls, and damage to reputation.

However, with the right tools, this complex terrain can be effectively managed. Enter the CARA Platform from Generis and Adlib Software, two solutions that have the potential to streamline compliance management in life sciences, making it more predictable and efficient. Read on to better understand the role of these systems in navigating global regulations and ensuring robust compliance across life science operations. Stay tuned as we unfold the ‘hows’ and ‘whys’ of these powerful solutions.

Understanding Global Regulations in Life Sciences

Across the globe, various regulatory bodies enforce strict guidelines to ensure the safety, efficacy, and quality of pharmaceuticals, biotech products, and medical devices.

The Food and Drug Administration (FDA) in the U.S., the European Medicines Agency (EMA) in Europe, and the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan, to name a few, have set forth regulations that life sciences organizations must adhere to. These regulations govern every aspect, from clinical trials and manufacturing practices to post-market surveillance and reporting.

For instance, the FDA’s 21 CFR Part 11 specifies the criteria for accepting electronic records and electronic signatures as trustworthy, reliable, and equivalent to paper records. The EMA’s Annex 11 sets the guidelines for computerized systems used in clinical trials. Similarly, PMDA’s ER/ES guidelines stipulate the requirements for the use of electronic data in the submission of applications.

Despite their diverse nomenclature and intricate details, the core purpose of these regulations is universal: to uphold product quality, ensure patient safety, and promote transparency in operations.

However, this diversity in regulatory rules across geographies can be daunting for life sciences companies operating on a global scale. Moreover, as these regulations are continually updated, companies must stay abreast of the changes and incorporate them promptly into their practices.

That’s where advanced document management and data processing tools like the CARA Life Sciences Platform and Adlib Software come into the picture. These platforms help organizations efficiently manage and process data, ensuring it is compliant with regulations no matter where they operate.

The Role of Enterprise Document Management in Compliance

At the heart of regulatory compliance in life sciences lies document management. Whether it’s research data, clinical trial reports, manufacturing processes, quality assurance records, or post-market surveillance reports, life sciences organizations generate a massive volume of documents that must be accurately maintained, accessed, and submitted to regulatory authorities.

Effective document management is, therefore, pivotal for several reasons:

Quality and Consistency: Regulatory bodies require documents to adhere to specific formats and standards. Effective document management ensures the creation of high-quality, consistent documents that meet these specifications.

Traceability: Traceability of all actions, from document creation and revisions to approvals and rejections, is a critical requirement in regulated environments. Document management solutions provide comprehensive audit trails that capture every action, thereby ensuring traceability.

Data Security: Ensuring the confidentiality, integrity, and availability of data is paramount. This includes implementing appropriate access controls, backup systems, and data protection measures.

Efficient Retrieval: During inspections or audits, organizations must promptly retrieve and present requested documents. Efficient document management expedites this process.

An Overview of CARA Life Sciences Platform and Adlib Software

Generis’ CARA and Adlib Software are industry-leading solutions that revolutionize the way life sciences companies manage and interact with their documents.

Adlib Software is a document conversion solution that helps organizations enhance content-centric processes by unlocking the value in unstructured content (learn more about Adlib for Life Sciences). Adlib converts various file types into high-quality, searchable PDFs, and automates the document workflows. Adlib is particularly helpful in standardizing content, its archival and document security, critical aspects in ensuring regulatory compliance.

Find our why PDF/A is the best option for long-term archival for data retention compliance >

Generis’ CARA is a leading content and information management platform, designed to offer flexible, user-friendly, and robust solutions for life sciences and other regulated industries. CARA offers features such as configurable dashboards, granular security, advanced workflow, and reporting capabilities. With CARA, organizations can efficiently manage their regulated documents and data, and streamline business processes for faster, more efficient compliance.

These two solutions individually offer great value to life sciences companies. However, when integrated, they create a powerful synergy, enabling companies to manage their documents and data with exceptional efficiency, accuracy, and compliance.

The Advantage of the CARA Life Sciences Platform in Navigating Global Regulations

Generis’ CARA offers an array of features that enable life sciences organizations to manage their compliance needs efficiently. Here’s how:

Advanced Document Management: CARA allows for efficient handling of all documents and content types in one central repository. Its robust version control ensures all changes are tracked, providing a clear audit trail, a fundamental requirement for regulatory compliance.

Granular Security and Access Control: CARA’s granular security model ensures that only authorized individuals have access to specific documents or actions. This is vital in maintaining the integrity and confidentiality of sensitive information, which is a key compliance requirement.

Automated Workflow: The platform enables the automation of business processes, including document review and approval workflows. It ensures that every step is completed and documented, enhancing transparency, reducing errors, and improving compliance.

Comprehensive Reporting: CARA’s reporting functionality allows organizations to generate detailed reports, facilitating effective monitoring of compliance status and providing insights into potential areas of risk.

Regulatory Submission Management: With CARA, organizations can manage their entire regulatory submission process, from planning and authoring to reviewing and submitting documents to regulatory bodies.

Let’s consider a real-world example of how Generis’ CARA enhances compliance in Life Sciences.

Consider a global medical device company that needs to meet various regulations across markets. It needs to control who can access and edit specific documents, track changes, and manage submissions effectively. With Generis’ CARA, they can streamline these processes. The granular security ensures only authorized individuals can access and make changes to documents. All edits are tracked for full traceability, and the submission management feature simplifies the regulatory submission process, enhancing overall compliance.

How Adlib Software Enhances Compliance

Adlib Software offers a host of features that directly support regulatory compliance in life sciences.

Standardization and Quality Enhancement: Adlib’s document rendering technology converts various document formats into high-quality, searchable PDFs. This standardization is critical for regulatory compliance as it ensures consistency across documents, making them easier to review and audit. Furthermore, Adlib’s technology enhances document quality, improving readability and minimizing formatting errors, thereby reducing the risk of non-compliance due to poor document quality.

Automated Document Workflows: Adlib can automate document-centric processes, such as formatting of headers/footers, addition of watermarks and dynamic tables of contents. By automating these tasks, Adlib not only accelerates workflows but also minimizes human errors that can lead to compliance breaches.

Metadata Management: Metadata, or data about data, is crucial in regulated environments for tracking and auditing purposes. Adlib allows for the creation and management of metadata, enabling better document control and traceability.

OCR: Adlib’s enterprise-grade Optical Character Recognition (OCR) capabilities can convert non-searchable content into searchable and editable formats. This is vital in compliance management, where quick search and retrieval of documents are often required during audits or inspections.

Let’s consider a real-world example of how Adlib enhances compliance.

A pharmaceutical company needs to submit a drug application to the FDA. The submission must adhere to strict standards, including document format and quality. With Adlib, the company can automate the conversion of various file types into a standardized, high-quality PDF format as required by the FDA. The automated process reduces errors, ensures consistency, and accelerates the submission process, thereby increasing the likelihood of successful, compliant submissions.

The Power of Integrating the CARA Platform and Adlib Software

The integration of the CARA Platform and Adlib Software brings together the best of both worlds, providing a comprehensive, unified platform for superior compliance management in life sciences.

Improved Workflow Efficiency: Adlib’s automated document transformation capabilities combined with CARA’s advanced document management, masterdata management and workflow automation result in highly efficient, streamlined processes. This not only accelerates compliance-related activities but also minimizes errors that can lead to non-compliance.

Enhanced Document Quality and Compliance: Adlib’s ability to convert various document types into standardized, high-quality PDFs seamlessly complements CARA’s document management capabilities. This ensures that all documents, irrespective of their origin, are consistent and meet the quality standards required for regulatory compliance.

Complete Traceability: With Adlib’s metadata management and CARA’s robust version control and audit trail capabilities, life sciences organizations gain complete traceability of their documents. Every action is logged, providing a clear path that can be audited and reviewed, thereby supporting compliance requirements.

Better Regulatory Submission Management: By leveraging Adlib’s document transformation capabilities and CARA’s submission management features, organizations can manage the entire regulatory submission process more efficiently and accurately. This improves the likelihood of successful, compliant submissions.


Generis’ CARA Platform and Adlib Software, two powerful solutions in their own right, offer a synergistic approach when integrated, transforming the way life sciences organizations manage their compliance. By enhancing document quality, streamlining workflows, improving traceability, and facilitating regulatory submissions, these platforms significantly simplify the compliance journey.

As regulations continue to evolve and expand, the demand for such robust, integrated solutions will only increase. Generis’ CARA Platform and the recently launched Adlib High Performance are at the forefront of this trend, empowering life sciences organizations to not just meet but exceed their compliance requirements. This not only minimizes the risk of non-compliance but also enables companies to focus more on their mission to advance health and wellbeing across the globe.

In this ever-evolving regulatory environment, the question is not if you can afford to invest in such compliance solutions, but rather, can you afford not to?